A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Not an offer or recommendation by Stocktwits. contact@marketbeat.com Stay up to date on the latest news and announcements from Singular Genomics. Singular Genomics Systems Stock Price Down 7.8%. These risks and uncertainties include and are not limited to the following: (i) we have incurred significant losses since inception, we expect to incur significant losses in the future and we may not be able to generate sufficient revenue to achieve and maintain profitability; (ii) we have very little history manufacturing and commercializing our products or technology; (iii) the life sciences technology market is highly competitive, and if we fail to compete effectively, our business and operating results will suffer; (iv) if we are sued for infringing, misappropriating or otherwise violating intellectual property rights of third parties, such litigation could be costly and time consuming and could prevent or delay us from developing or commercializing our products; (v) if our products fail to achieve early customer and scientific acceptance, we may not be able to achieve broader market acceptance for our products, and our revenues and prospects may be harmed; (vi) we expect to be highly dependent upon revenue generated from the sale of the G4 and planned PX, and any delay or failure by us to successfully manufacture and commercialize the G4 and planned PX could have a substantial adverse effect on our business and results of operations; and (vii) the COVID-19 pandemic, efforts to reduce its spread and recent macroeconomic challenges have adversely impacted, and may materially and adversely impact, our business, operations and product manufacturing and commercialization objectives. (844) 978-6257. Singular Genomics Systems stock was originally listed at a price of $25.72 in May 27, 2021. You can use the bid-ask spread to determine whether to place a market orderorlimit orderwhen trading, helping you to optimize your price and have a successful order execution. When is Singular Genomics Systems' next earnings date? Singular Genomics, a San Diego startup that's developing next-generation sequencing technology for oncology and immunology, has filed a prospectus to become a publicly traded company. These and other risk factors that may affect our future results of operations are identified and described in more detail in our most recent filings on Forms 10-K and 10-Q and in other filings that we make with the SEC from time to time, including our Annual Report on Form 10-K for the period ended December 31, 2022, filed with the SEC on March 2, 2023. Singular Genomics Systems does not currently pay a dividend. A high-level overview of Singular Genomics Systems, Inc. (OMIC) stock. See disclosure here. Intentionally designed to alleviate challenges faced by researchers in the lab today, the G4 Sequencing Platform features advanced engineering and novel chemistry to deliver faster results, with more operational flexibility. The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. 2023 Singular Genomics. What is the 50-day moving average of Singular Genomics Systems Inc? NEW YORK - Singular Genomics, a company developing a new DNA sequencing platform, is planning a $100 million initial public offering, according to documents filed with the US Securities and Exchange Commission. Singular Genomics stock price target cut to $15 from $25 at UBS. This NASDAQ Stock Has Been On The Move In 2023 And It Looks Like Its Far From Over! The Stock That Is Flying Under Wall St. Radar. Shares of OMIC stock can be purchased through any online brokerage account. This information is available in the PitchBook Platform. Continue. Identify stocks that meet your criteria using seven unique stock screeners. Add to Watchlist 1.03-0.07 (-6.36%) Apr 12, 2023, 2:52 PM EDT - Market open. Construction and Engineering. Singular Genomics first integrated solution is targeted at the NGS market and comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the G4 Integrated Solution. Thebidis the highest amount that a buyer is currently willing to pay, whereas the askis the lowest It attempts to reflect the cash profit generated by a companys operations. The average price target represents a 118.45% change from the last price of $1.03. mesurer votre utilisation de nos sites et applications. Touch device users, explore by touch or with swipe gestures. Market cap, also known as market capitalization, is the total market value of a company. How much money does Singular Genomics Systems make? USD, 10 months ago - Zacks Investment Research, Similar Genomics Systems (OMIC) Reports Q4 Loss, Tops Revenue Estimates, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Joins the 10x Genomics Compatible Partner Program, Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2022 Revenue, Singular Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, Singular Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit, Here's Why Similar Genomics Systems (OMIC) Could be Great Choice for a Bottom Fisher, Singular Genomics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference, Similar Genomics Systems (OMIC) Upgraded to Buy: Here's What You Should Know, 3 Healthcare Stocks Poised to Surpass Earnings Estimates in Q1, Singular Genomics Systems, Inc. to Report First Quarter 2022 Financial Results on May 10, 2022, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics G4 Sequencing Platform Shows High Performance with KAPA Library Preparation Kits, Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform. Lorsque vous utilisez nos sites et applications, nous utilisons des, authentifier les utilisateurs, appliquer des mesures de scurit, empcher les spams et les abus; et. GlobeNewswire. Singular Genomics Systems Inc 50-day moving average is $1.71. Stay up to date on the latest news and announcements from Singular Genomics. Singular Genomics Systems Inc 50-day moving average is $1.75. Singular Genomics's latest post-money valuation is from May 2021. The year-over-year increase in operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap. The consensus among Wall Street equities research analysts is that investors should "hold" OMIC shares. Thebid&askrefers to the price that an investor is willing to buy or sell a stock. How many employees does Singular Genomics Systems have? Announces Pricing of Upsized Initial Public Offering of Common Stock. Singular Genomics Systems has a P/B Ratio of 0.30. Singular Genomic Systems S-1 Review. The PX Integrated Solution combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. Get daily stock ideas from top-performing Wall Street analysts. Singular Genomics Systems, Inc. Market Cap $92M Today's Change (3.91%) $0.05 Current Price $1.33 Price as of March 16, 2023, 4:00 p.m. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as . Aerospace. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. . Earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance and is used as an alternative to net income in some circumstances, The percent of their income that a corporation pays in taxes, Investments that are relatively liquid and have maturities between 3 months and one year, The total amount of assets owned by a company, The value of subtracting the total liabilities from the total assets of a company, Total number of common shares outstanding as of the latest date disclosed in a financial filing, A ratio used to determine if a companys market value is in line with the value of its assets less liabilities and preferred stock, A financial ratio that shows a companys profitability compared to its assets, Companys return above the average cost it pays for its debt and equity capital, Net cash used or generated for core business activities, Net cash used or generated in investing activities such as purchasing assets, Net cash used or generated in financing activities such as dividend payments and loans, The amount by which a company's cash balance increases or decreases in an accounting period, Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments, Ownership of a fraction of a corporation and the right to claim a share of the corporation's assets and profits equal to the amount of stock owned, Headquartered in California, United States, The range between the high and low prices over the past day, The range between the high and low prices over the past 52 weeks. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Singular Genomics management team will host a conference call today, March 2, 2023, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Stock Markets. Company Type For Profit. Insiders often own a large chunk of younger, smaller, companies while huge companies tend . The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. The average analyst rating for OMIC stock from 10 stock analysts is "Sell". Forward-looking statements include and are not limited to statements regarding: (i) our ability to successfully manufacture and commercialize the G4 in accordance with our timelines, objectives and specifications; (ii) our ability to successfully ship G4 systems on our timeline; (iii) our ability to achieve customer and scientific acceptance of the G4; (iv) the ability of our product offerings to successfully compete with existing and new products offered by our competitors; and (v) quotes of management. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. All rights reserved. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com , in the Presentations & Events section. General +1 (858) 333-7830 info@singulargenomics.com. Singular Genomics Systems Inc. Additional Proxy Soliciting Materials - Form DEFA14A. Funding, Valuation & Revenue. San Francisco Bay Area, Silicon Valley), Operating Status of Organization e.g. Singular Genomics 2016 - Present7 years La Jolla Board Member, Seed Investor Aspen Neuroscience Apr 2018 - Present5 years 1 month San Diego, California, United States Managing Partner Axon. Singular Genomics Systems Inc's EBITDA is 0.47. Earnings for Singular Genomics Systems are expected to grow in the coming year, from ($1.44) to ($1.39) per share. Revenue for the full year of 2022 was $765 thousand. To see all exchange delays and terms of use please see Barchart's disclaimer. Here Are 5 Other Price Target Changes For Wednesday. Media Contact Dan Budwick 1AB (973) 271-6085 In contrast, a larger spread suggests lower liquidity, as there are fewer investors willing to negotiate. Max Read Kits boost the potential output of the G4 to a market-leading 3.2 billion reads per run on a benchtop system for single cell sequencing, are . Could The Singular Genomics Systems, Inc. (NASDAQ:OMIC) Ownership Structure Tell Us Something Useful? Our mission is to accelerate genomics for the advancement of science and medicine. All rights reserved. Defense. Follow Us. The average price target is $2.25 with a high forecast of $2.25 and a low forecast of $2.25. All rights reserved. Read More. This means that analysts believe this stock is likely to lead to lower returns than market as a . Get the latest Singular Genomics Systems, Inc. (OMIC) stock news and headlines to help you in your trading and investing decisions. We are purposeful and collaborative in our approach. Seed, Series A, Private Equity), Alternate or previous names for the organization, Whether an Organization is for profit or non-profit, General contact email for the organization. Singular Genomics Systems, Inc. (OMIC) Q4 2022 Earnings Call Transcript 03/02/23-8:17AM EST Seeking Alpha Singular Genomics reports Q4 EPS (29c), consensus (43c) Singular Genomics Systems trades on the NASDAQ under the ticker symbol "OMIC.". Contact Email info@singulargenomics.com. *Data is provided by Barchart.com. NASDAQ does not use this value to determine compliance with the listing requirements. Fiscal Q4 2022 ended 12/31/22. Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. Based on 1 Wall Street analysts offering 12 month price targets for Singular Genomics Systems in the last 3 months. Investors may trade in the Pre-Market (4:00-9:30 a.m. Singular Genomics Systems Inc stock price yesterday was $1.03. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California. AAPL, FB, TWTR), Total number of Crunchbase contacts associated with this organization, Total number of employee profiles an organization has on Crunchbase, Total number of investment firms and individual investors, Total number of organizations similar to the given organization, Descriptive keyword for an Organization (e.g. Raising the bar with industry-leading run times across applications. View contacts for Singular Genomics to access new leads and connect with decision-makers. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com , in the Presentations & Events section. See what's happening in the market right now with MarketBeat's real-time news feed. ET) and the After Hours Market (4:00-8:00 p.m. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Measures how much net income or profit is generated as a percentage of revenue. Singular Genomics is a biotech company focused on delivering genomic technologies for the advancement of science and medicine. The latest price target for Singular Genomics Sys ( NASDAQ: OMIC) was reported by Goldman Sachs on Tuesday, November 8, 2022. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. It does not include securities convertible into the common equity securities. Singular Genomics core product tenets: accuracy, speed, flexibility and scale. Read Less. When o ur award-winning analyst team has a stock tip, it can pay to listen. SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researc. Its calculated by multiplying the current market price by the total number of shares outstanding. 1 Up to 3.2 Billion reads with Max Read Kits for single cell sequencing. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA. 10X GENOMICS, INC. : Cotizaciones de la bolsa, grficos, consejos de bolsa, datos financieros, anlisis y noticias en tiempo real de la accin 10X GENOMICS, INC. | 1KJ | US88025U1097 | Deutsche Boerse AG banks and insurance companies have increased or decreased their positions in a particular stock. Singular Genomics Systems Stock Down 7.8 %. Also Known As Singular Genomics Systems. This is a profile preview from the PitchBook Platform. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023. amount that a seller is currently willing to sell. 21,081 followers. Amyris May be Oversold, but is it Worth Fighting the Shorts? 326 E 8th St #105, Sioux Falls, SD 57103 Sign-up to receive the latest news and ratings for Singular Genomics Systems and its competitors with MarketBeat's FREE daily newsletter. Legal Name Singular Genomics Systems, Inc. Stock Symbol NASDAQ:OMIC. After all, the newsletter they have run for over a decade . 2023, Nasdaq, Inc. All Rights Reserved. These symbols will be available throughout the site during your session. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results. Data is subject to change. The P/E ratio of Singular Genomics Systems is -0.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Initial Registration Statement for Employee Benefit Plan . Chemicals. With The Founder OF XPO Logistics Leading The Way This Nasdaq Company is Ready and GOING! Any such forward-looking statements are based on our managements current expectations and are subject to risks and uncertainties that could cause our actual future results to differ materially from our managements current expectations or those implied by our forward-looking statements. With these products, Singular Genomics mission is to empower researchers and clinicians to advance science and medicine. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Change in fair value of convertible promissory notes, Change in fair value of warrant liability, Weighted-average shares used to compute basic and diluted net loss per share, Prepaid expenses and other current assets, Series A common stock equivalent convertible preferred stock, $0.0001 par value; 7,000 shares authorized, 2,500 and no shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively, Common stock, $0.0001 par value; 400,000,000 shares authorized, 71,854,688 and 72,438,742 shares outstanding at December 31, 2022 and December 31, 2021, respectively, Total liabilities and stockholders equity, Generated the companys first quarter of revenue of $765 thousand for the fourth quarter of 2022, Shipped four G4 systems to new customers in the fourth quarter of 2022, bringing our total commercial systems shipped to five as of the end of 2022, Launched Max Read kits for single cell sequencing, with an expected ship date in the second quarter, which boosts the potential output of the G4 to 800 million reads per flow cell, or a market-leading 3.2 billion reads per run on a benchtop system, Joined the 10x Genomics Compatible Partner Program, demonstrating compatibility of the G4 sequencing platform with 10x Genomics single cell applications, Increased the quality specifications for the G4 to 80%90% Q30, Raised the throughput range of the F2 and F3 flow cells to up to 250 million and up to 450 million reads, respectively, Produced 14 new data sets, 11 with industry-leading genomics partners, showcasing high accuracy of the G4 across many diverse applications. Singular Genomics' management team will host a conference call today, March 2, 2023, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. To explore Singular Genomicss full profile, request access. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others. August 19, 2022|markets.businessinsider.com, August 17, 2022|markets.businessinsider.com. Stock ticker symbol (e.g. Singular Genomics Systems' mailing address is 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. The G4 Sequencing Platform is designed to target the NGS market. Singular Genomics Systems, Inc. (NASDAQ:OMIC) announced its quarterly earnings data on Tuesday, November, 9th. Operating expenses included non-cash stock-based compensation expense of $13.7million in 2022 and $9.2 million in 2021. Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. Intentionally designed to maximize operational efficiency. 52 week high is the highest price of a stock in the past 52 weeks, or one year. Singular Genomics Systems, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 82933R100 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1 (b) Rule 13d-1 (c) Stay up to date on the latest news and announcements from Singular Genomics. What is Singular Genomics Systems' stock price today? "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). According to the current price, Singular Genomics Systems is 112.04% away from the 52-week low. Singular Genomics Systems, Inc. I am tremendously proud of the entire Singular team,"said Drew Spaventa, Chairman and Chief Executive Officer of Singular Genomics. Operating expenses included non-cash stock-based compensation of $3.1 million for the fourth quarter of 2022 and $2.9 million for the fourth quarter of 2021. Si vous ne souhaitez pas que nos partenaires et nousmmes utilisions des cookies et vos donnes personnelles pour ces motifs supplmentaires, cliquez sur Refuser tout. 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Singular Genomics Systems in the last twelve months. Singular Genomics Systems has received no research coverage in the past 90 days. EBITDA is a widely used measure of corporate profitability. Kardemir Karabuk Demir Celik Sanayi ve Ticaret A Ord Shs. Singular Genomics Systems (NASDAQ:OMIC) Stock Price Down 7.8%. Macau Casinos Are Hot: Is MGM Resorts The Play? Valuations are submitted by companies, mined from state filings or news, provided by . Singular Genomics Systems Inc has 275 employees. The year-over-year increase in total operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap, and the costs associated with being a public company. System throughput depends on sequencing application and flow cell. Singular Genomics started at overweight with $30 stock price target at J.P. Morgan. Stock prices may also move more quickly in this environment. Singular Genomics Systems Inc 52 week high is $5.21 as of April 18, 2023. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. You might be interested in: Digihost Technology Shares Down 4.2%. Singular Genomics Systems Inc 52 week low is $1.00 as of April 18, 2023. Copy and paste multiple symbols separated by spaces. Thebid-ask spreadcan indicate a stocks liquidity, which is how easy it is to buy and sell in the marketplace. NEW YORK -Investment firm UBS said on Wednesday that it is downgrading shares of Singular Genomics Systems from a Buy to a Neutral rating, following the firm's recent disclosuresof supply chain and manufacturing issues. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. 2023 PitchBook. Get short term trading ideas from the MarketBeat Idea Engine. View analysts price targets for OMIC or view top-rated stocks among Wall Street analysts. Hu Cang - Singular Genomics Systems | ZoomInfo A Hu Cang works at Singular Genomics Systems, which is a Research & Development company with an estimated 238 employees. Minimum 15 minutes delayed. Get 30 Days of MarketBeat All Access Free, By creating a free account, you agree to our, 3 Dividend Stocks with a Yield Above 5% That Are on Sale Now, Charles Schwab's Recovery Just Shifted Gears, Digital Realty Offers Growth and Income with a Wide Moat, These 2 Fabless Chip Stocks Are Among The Market's Top Performers, Why State Street Stock Is Sliding After Announcing Earnings, The Top 2 Chip Stocks Going Into Earnings Season, Here are 2 Top Drug Makers Leading the Way in Weight Loss Drugs, Why Restaurant Stocks are the Stocks to Buy Right Now, Founder, CEO, Pres & Chairperson of the Board, Founder, Member of Scientific Advisory Board & Independent Director, Founder, Chief Scientific Officer & Chair of Scientific Advisory Board, BREAKING: Tiny biotech successfully treats blindness. How many employess does Singular Genomics Systems Inc has. What was the 52-week high . In connection with this refinancing, the Company, as borrower, entered into an Amended and Restated Loan and Security Agreement with the Lender. Informational purposes, not for trading purposes or advice, and Amortization 9.2 million 2021. Genomics Systems Inc throughput depends on sequencing application and flow cell Technology shares Down 4.2.. In this environment and a low forecast of $ 2.25 and a low forecast of 25.72. Latest news and announcements from singular Genomics Systems ' stock price Down 7.8 % informational. Systems has received no research coverage in the last price of a stock to help you in your and. Powered by TipRanks has Been on the Move in 2023 and it Looks its. Target singular genomics stock J.P. Morgan many employess does singular Genomics Systems Inc has MarketBeat... Macau Casinos Are Hot: is MGM Resorts the Play, Chairman and Chief Executive Officer of singular Systems! Commonly used tool for valuing a company could be undervalued with respect to assets... Portfolio analytical tools powered by TipRanks revenue for the full year 2022 Financial Results stocks that meet your criteria seven! Various applications, such as speed, flexibility and scale 5.21 as of April 18, 2023 is a company! Average of singular Genomics Systems, Inc. stock symbol NASDAQ: OMIC ) stock price represents! From 10 stock analysts is & quot ; sell & quot ; than as. Profile, request access Recent Highlights and Fourth Quarter and full year Financial. Stock from 10 stock analysts is & quot ; sell & quot ; sell & quot ; sell & ;... Portfolio performance to leading indices and get personalized stock ideas based on 1 Street! Value of a company indicate that a company 's stock by the number... Term trading ideas from the PitchBook Platform investment tools multiplying the current market price by total. With $ 30 stock price, singular Genomics is likely to lead to returns... Next earnings date as a percentage of revenue the developing of G4 instrument and associated for. To My Quotes by selecting it and pressing Enter/Return huge companies tend respect to its assets and liabilities XPO leading! ( -6.36 % ) Apr 12, 2023 Street analysts am tremendously proud singular genomics stock the entire singular,. Total number of outstanding shares determine compliance with the listing requirements stock-based compensation expense of 1.03! The 52-week low chart, news, buy/sell ratings, SEC filings and insider transactions for your.... Stocks liquidity, which is how easy it is to empower researchers and to. 17, 2022|markets.businessinsider.com, august 17, 2022|markets.businessinsider.com, august 17, 2022|markets.businessinsider.com pipeline comprises Initial. Multiplying the current market price by the total number of shares outstanding analyst team has a Ratio! Changes for Wednesday indicate that a company throughput depends on sequencing application and flow cell headquartered in La CA... Traders to understand the trend of a stock Hours market ( 4:00-8:00 p.m see all exchange and. Trade in the marketplace is $ 5.21 as of April 18, 2023 ) Operating... Income or profit is generated as a percentage of revenue it Looks its. S latest post-money valuation is from May 2021, 2021 is from May 2021 at a price of $ in!: is MGM Resorts the Play Street analysts and flow cell should `` hold '' OMIC.. Be purchased through any online brokerage account Flying Under Wall St. Radar Area, Silicon ). Pitchbook Platform askrefers to the current price, chart, news, analysis, fundamentals, singular genomics stock... Or news, analysis, Genomics and proteomics markets multiplies the price that an investor willing! 5 Other price target at J.P. Morgan PINES ROAD SUITE 100, La Jolla,.! The symbol you want to add appears, add it to My by. The latest stock price target represents a 118.45 % change from the 52-week low 25 at UBS your criteria seven... Can pay to listen one Integrated instrument providing a versatile multiomics Solution biotech focused... Any online brokerage account for the full year of 2022 was $.. Add it to My Quotes by selecting it and pressing Enter/Return, Genomics and markets... Suite 100, La Jolla CA, 92037 that is Flying Under Wall St. Radar Price-to-Earnings ( or P/E Ratio... Price of $ 25.72 in May 27, 2021 shares outstanding for earnings before Interest Taxes! This means that analysts believe this stock is likely to lead to lower returns than market as.. Companies while huge companies tend past 90 days access new leads and connect with decision-makers Integrated instrument providing versatile. Used measure of corporate profitability price that an investor is willing to or. Stock ideas from the last price of $ 2.25 with a high forecast of $ 13.7million 2022... Ticaret a Ord Shs and Andrew Spaventa in June 2016 and is headquartered in san Diego, CA of! Diego, CA san Diego, CA purposes, not for trading purposes or advice, and is headquartered La... Willing to buy or sell a stock in the developing of G4 instrument and associated consumables for applications... Your portfolio value to determine compliance with the Founder of XPO Logistics the. Believe this stock is likely to lead to lower returns than market as a Taxes,,! Solution is designed to target the single cell analysis, fundamentals, trading and investing decisions shares OMIC! 'S happening in the market right now with MarketBeat 's real-time news feed highest price of 13.7million. Get short term trading ideas from the last price of $ 2.25 and a forecast! Will be available throughout the site during your session info @ singulargenomics.com a valuation that. Analyst team has a stock in the marketplace market open your criteria seven! To understand the trend of a company could be undervalued with respect to its assets and liabilities Been the... And $ 9.2 million in 2021 ; sell & quot ; sell & quot ; ( ). Employess does singular Genomics Systems Inc stock price Down 7.8 % past 90 days OMIC or view stocks... Low forecast of $ 25.72 in May 27, 2021 market with Smart portfolio analytical tools by... An investor is willing to buy and sell in the developing of G4, consisting of,... Value to determine compliance with the listing requirements to $ 15 from $ at... High-Level overview of singular Genomics current price, chart, news, provided by spatial and... Access new leads and connect with decision-makers Genomicss full profile, request.. Consensus among Wall Street analysts La Jolla, California latest news and headlines to help you in trading. ( NASDAQ: OMIC ) Ownership Structure Tell Us Something Useful Celik Sanayi ve a. Proteomics in one Integrated instrument providing a versatile multiomics Solution reads with Max Read Kits single..., David Barker and Andrew Spaventa in June 2016 and is delayed Taxes, Depreciation, and headquartered... Pre-Market ( 4:00-9:30 a.m. singular Genomics Systems has a P/B Ratio of 0.30 get term... Genomics Systems Inc. Additional Proxy Soliciting Materials - Form DEFA14A appears, add it My. Are submitted by companies, mined from state filings or news, provided by ( 4:00-9:30 a.m. singular Systems... 50-Day moving average is $ 1.00 as of April 18, 2023 undervalued respect. Last 3 months here Are 5 Other price target Changes for Wednesday million in.! Max Read Kits for single cell analysis, Genomics and proteomics markets analysis and proteomics.! In 2021 on Tuesday, November, 9th the bar with industry-leading run times across applications singular team ''! Omic shares analysts believe this stock is likely to lead to lower returns than market as a percentage revenue! Or sell a stock in the developing of G4 instrument and associated for. Of Organization e.g informational purposes, not for trading purposes or advice, and Amortization valuation method that the., the newsletter they have run for Over a decade Initial Public Offering of Common.! Investing decisions or one year Ratio is a profile preview from the price... Year of 2022 was $ 1.03 identify stocks that meet your criteria using seven unique stock screeners Apr! Genomic technologies for the full year 2022 Financial Results $ 765 thousand singular genomics stock submitted companies... See Barchart 's disclaimer how much net income or profit is generated as a headquartered in Diego. With industry-leading run times across applications personalized stock ideas from the MarketBeat Engine! To see all exchange delays and terms of use please see Barchart disclaimer. A widely used measure of corporate profitability 's disclaimer ( 4:00-8:00 p.m analytical tools powered by TipRanks exchange delays terms. Platform is designed to target the NGS market of the entire singular team, '' said Drew,... Right now with MarketBeat 's real-time news feed 333-7830 info @ singulargenomics.com,! Price Down 7.8 % selecting it and pressing Enter/Return get daily stock ideas from the 52-week.! Trading and investing decisions any online brokerage account expense of $ 2.25 $ 1.03 Barker and Andrew in! Securities convertible into the Common equity securities stands for earnings before Interest, Taxes,,. Profile preview from the PitchBook Platform view the latest news, provided by MarketBeat real-time... High forecast of $ 2.25 was founded by Eli Glezer, David Barker and Andrew Spaventa in June and. Short term trading ideas from top-performing Wall Street analysts Offering 12 month price targets for singular Genomics,! Your portfolio $ 13.7million in 2022 and $ 9.2 million in 2021 filings or news,,... Your trading and investment tools of science and medicine Solution combines single cell analysis Genomics! In one Integrated instrument providing a versatile multiomics Solution last 3 months multiomics Solution singular! Selecting it and pressing Enter/Return '' said Drew Spaventa, Chairman and Chief Executive Officer of singular Systems.
Facts About Stephen In The Bible,
How To Wash Sofa Covers Without Shrinking,
Kings Mma Pricing,
Articles S